Increased risk of resistance or adverse effects.
Etravirine should not be combined with other NNRTIs.
Source: G&G 14e · p1245-1266
Antiretroviral
Also known as ETR, INTELENCE, ETV
NNRTIs inhibit reverse transcriptase, an enzyme crucial for HIV replication. After the virus enters a host cell and uncoats, reverse transcriptase is responsible for copying the single-stranded HIV RNA genome into double-stranded DNA. By inhibiting this process, Etravirine prevents the integration of viral DNA into the host cell genome, thereby blocking the production of new infectious virions.
Manufacturer advises use only if potential
Increased risk of resistance or adverse effects.
Etravirine should not be combined with other NNRTIs.
Source: G&G 14e · p1245-1266
Potential loss of valbenazine efficacy.
Not recommended.
Source: G&G 14e · p372
Drug interaction classified as: metabolism
Source: DDInter
Decreased artemether levels.
Source: DDInter
Potentially unsafe or ineffective coadministration.
Etravirine should not be administered with atazanavir/ritonavir in the absence of better data to guide dosing.
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, BNF·Verified: 2026-05-13 · House clinical team